Observational studyESMO open2024

Activity of osimeRTInib in non-small-cell lung Cancer with UNcommon epidermal growth factor receptor mutations: retrospective Observational multicenter study (ARTICUNO).

E G Pizzutilo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.